This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
L Anila & NR Vijayalakshmi (2002) Flavonoids from Emblica officinalis and Mangifera indica – effectiveness for dyslipidemia. J Ethnopharmacol 79, 81–87.
L Anila & NR Vijayalakshmi (2003) Antioxidant action of flavonoids from Mangifera indica and Emblica officinalis in hypercholesterolemic rats. Food Chemistry 83, 569–574.
MZ Asmawi , H Kankaanranta , E Moilanen & H Vapaatalo (1993) Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacol 45, 581–584.
AS Baldwin (2001) The transcription factor NF-κB and human disease. J Clin Invest 107, 3–6.
SK Bandyopadhyay , SC Pakrashi & A Pakrashi (2000) The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J Ethnopharmacol 70, 171–176.
O Barbier , P Torra , Y Duguay , C Blanquart , JC Fruchart , C Glineur & B Staels (2002) Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 22, 717–726.
JP Berger , TE Akiyama & PT Meinke (2005) PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 26, 244–251.
C Blanquart , O Barbier , JC Fruchart , B Staels & C Glineur (2003) Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 85, 267–273.
JA Buege & SD Aust (1978) Microsomal lipid peroxidation. Methods Enzymol 52, 302–306.
SL Chan & VC Yu (2004) Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clin Exp Pharmacol Physiol 31, 119–128.
YH Choi , SJ Lee , P Nguyen , JS Jang , J Lee , ML Wu , E Takano , M Maki , PA Henkard & JB Trepel (1997) Regulation of cyclin D1 by calpain protease. J Biol Chem 272, 28479–28484.
CA De la Lastra & I Villegas (2005) Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 49, 405–430.
S El-Mekkawy , MR Meselhy , IT Kusumoto , S Kadota , M Hattori & T Namba (1995) Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull 43, 641–648.
AU Ferrari , A Radaelli & M Centola (2003) Aging and the cardiovascular system. J Appl Physiol 95, 2591–2597.
DR Green & JC Reed (1998) Mitochondria and apoptosis. Science 281, 1309–1312.
DM Hockenbery , ZN Oltvai , XM Yin , CL Milliman & SJ Korsmeyer (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241–251.
I Inoue , S Noji , MZ Shen , K Takahashi & S Katayama (1997) The peroxisome proliferator-activated receptor α (PPARα) regulates the plasma thiobarbituric acid-reactive substance (TBARS) level. Biochem Biophys Res Commun 237, 606–610.
I Inoue , F Itoh , S Aoyagi , (2002) Fibrate and statin synergistically increase the transcriptional activities of PPARα/RXRα and decrease the transactivation of NFκB. Biochem Biophys Res Commun 290, 131–139.
RF Itzhaki & DM Gill (1964) A micro-biuret method for estimating proteins. Anal Biochem 9, 401–410.
D Johnson & H Lardy (1967) Isolation of liver or kidney mitochondria. Methods Enzymol X, 94–96.
JK Jose & R Kuttan (1995) Antioxidant activity of E. officinalis. J Clin Biochem Nutr 19, 63–70.
JK Jose , G Kuttan & R Kuttan (2001) Antitumour activity of Emblica officinalis. J Ethnopharmacol 75, 65–69.
K Jung & M Pergande (1985) Influence of cyclosporin A on the respiration of isolated rat kidney mitochondria. FEBS Lett 183, 167–169.
CH Kim , DH Park , A Chung , Y Zou , KJ Jung , BK Sung , BP Yu & HY Chung (2004) Proteomic analysis of post-mitochondrial fractions of young and old rat kidney. Exp Geront 39, 1155–1168.
HJ Kim , T Yokozawa , HY Kim , C Tohda , TP Rao & LR Juneja (2005) Influence of amla (Emblica officinalis Gaertn.) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats. J Nutr Sci Vitaminol 51, 413–418.
HJ Kim , BP Yu & HY Chung (2002) Molecular exploration of age-related NF-κB/IKK downregulation by calorie restriction in rat kidney. Free Radic Biol Med 32, 991–1005.
JA Knight (2001) The biochemistry of aging. Adv Clin Chem 35, 1–62.
Y Lavrovsky , B Chatterjee , RA Clark & AK Roy (2000) Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 35, 521–532.
Q Li & IM Verma (2002) NF-κB regulation in the immune system. Nat Immunol 2, 725–734.
MT Lin & MF Beal (2003) The oxidative damage theory of aging. Clin Neurosci Res 2, 305–315.
K Pahan , M Jana , X Liu , BS Taylor , C Wood & SM Fischer (2002) Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric oxide synthase in human astrocytes. J Biol Chem 277, 45984–45991.
P Parini , B Angelin & M Rudling (1999) Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats. Arterioscler Thromb Vasc Biol 19, 832–839.
JM Peters , N Hennuyer , B Staels , JC Fruchart , C Fievet , FJ Gonzalez & J Auwerx (1997) Alteration in lipoprotein metabolism in peroxisome proliferator-activated receptor-α deficient mice. J Biol Chem 272, 28307–28312.
HF Poon , V Calabrese , G Scapagnini & DA Butterfield (2004) Free radicals and brain aging. Clin Geriatr Med 20, 329–359.
ME Poynter & RA Daynes (1998) Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses nuclear factor-κB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 273, 32833–32841.
M Ricote & CK Glass (2001) New roles for PPARs in cholesterol homeostasis. Trends Pharmacol Sci 22, 441–443.
MC Sabu & R Kuttan (2002) Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 81, 155–160.
H Sakurai , Y Hisada , M Ueno , M Sugiura , K Kawashima & T Sugita (1996) Activation of transcription factor NF-κB in experimental glomerulonephritis in rats. Biochim Biophys Acta 1316, 132–138.
AK Samhan-Arias , FJ Martín-Romero & C Gutiérrez-Merino (2004) Kaempferol blocks oxidative stress in cerebellar granule cells and reveals a key role for reactive oxygen species production at the plasma membrane in the commitment to apoptosis. Free Radic Biol Med 37, 48–61.
E Sanguino , M Ramón , L Michalik , W Wahli , M Alegret , RM Sánchez , M Vázquez-Carrera & JC Laguna (2004 a) Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARα. Biochem Pharmacol 67, 157–166.
E Sanguino , N Roglans , M Alegret , RM Sánchez , M Vázquez-Carrera & JC Laguna (2004b) Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs. Biochem Pharmacol 68, 1411–1421.
E Sanguino , N Roglans , M Alegret , RM Sánchez , M Vázquez-Carrera & JC Laguna (2005) Atorvastatin reverses age-related reduction in rat hepatic PPARα and HNF-4. Br J Pharmacol 145, 853–861.
NF Spencer , ME Poynter , SY Im & RA Daynes (1997) Constitutive activation of NF-κB in an animal model of aging. Int Immunol 9, 1581–1588.
CP Thakur (1985) Emblica officinalis reduces serum, aortic and hepatic cholesterol in rabbits. Experientia 41, 423–424.
MJ Toth & A Tehernof (2000) Lipid metabolism in the elderly. Eur J Clin Nutr 54, S121–S125.
AP Wickens (2001) Ageing and the free radical theory. Respir Physiol 128, 379–391.
RJ Williams , JPE Spencer & C Rice-Evans (2004) Flavonoids: antioxidants or signaling molecule? Free Radic Biol Med 36, 838–849.
SO Yoon , CH Yun & AS Chung (2002) Dose effect of oxidative stress on signal transduction in aging. Mech Ageing Dev 123, 1597–1604.
BP Yu & HY Chung (2001) Oxidative stress and vascular aging. Diabetes Res Clin Pract 54, S73–S80.
BP Yu & HY Chung (2006) Adaptive mechanisms to oxidative stress during aging. Mech Ageing Dev 127, 436–443.
YJ Zhang , T Tanaka , CR Yang & I Kouno (2001) New phenolic constituents from the fruit juice Phyllanthus emblica. Chem Pharm Bull 49, 537–540.